Hansa Biopharma AB (publ) (FRA:24H)

Hansa Biopharma AB Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 4, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	310	232	124	232	384	1,064
Market Cap Growth	76.71%	87.69%	-46.65%	-39.67%	-63.91%	232.43%
Enterprise Value	372	267	126	194	288	918
Last Close Price	3.04	3.48	2.45	4.39	8.18	23.48
PS Ratio	19.20	15.52	10.25	16.70	116.57	1753.27
PB Ratio	-6.12	-4.51	-8.18	4.28	5.21	8.61
P/TBV Ratio	-	-	-	4.47	5.42	8.83
EV/Sales Ratio	22.79	17.89	10.41	13.96	87.45	1512.21
Debt / Equity Ratio	-1.65	-1.83	-5.16	1.31	0.05	0.00
Asset Turnover	0.21	0.19	0.10	0.11	0.03	0.01
Inventory Turnover	26.30	40.53	50.80	63.34	90.74	-
Quick Ratio	1.10	2.22	2.57	5.91	5.33	12.13
Current Ratio	1.11	2.29	2.66	6.06	5.50	12.20
Return on Equity (ROE)	-	-	-382.37%	-89.84%	-54.84%	-46.63%
Return on Assets (ROA)	-42.29%	-43.41%	-36.55%	-26.67%	-27.56%	-25.32%
Return on Capital (ROIC)	-70.95%	-66.46%	-47.25%	-32.93%	-33.06%	-29.20%
Return on Capital Employed (ROCE)	-177.00%	-115.90%	-113.50%	-40.50%	-64.10%	-32.20%
Earnings Yield	-18.70%	-30.37%	-60.53%	-23.68%	-13.88%	-3.94%
FCF Yield	-	-25.39%	-55.02%	-19.61%	-12.25%	-2.72%
Buyback Yield / Dilution	-23.08%	-19.59%	-16.95%	-1.01%	-5.45%	-5.39%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.